Stay updated on Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1; the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:16:15.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    There are no additions or deletions in the provided changes. The page context shows a 403 Forbidden error, indicating restricted access.
    Difference
    0.2%
    Check dated 2026-09-26T22:01:42.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the expected study record content and preventing access to the study details.
    Difference
    19%
    Check dated 2026-09-19T20:36:17.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6. This reflects a small internal update to the page’s content or metadata without altering study information.
    Difference
    0.1%
    Check dated 2026-08-29T19:35:48.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The web page shows a new revision version, updating from v3.6.4 to v3.6.5. This indicates a minor platform or content management update rather than a change to the study details presented on the page.
    Difference
    0.1%
    Check dated 2026-08-08T23:13:13.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4 instead of v3.6.3, indicating a minor site version update; the study details and layout remain effectively the same.
    Difference
    0.1%
    Check dated 2026-07-25T16:40:26.000Z thumbnail image

Stay in the know with updates to Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial page.